Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Ascendis Pharma A/S ADR (NASDAQ: ASND) closed at $160.99 down -1.14% from its previous closing price of $162.84. In other words, the price has decreased by -$1.14 from its previous closing price. On the day, 0.55 million shares were traded.
Ratios:
For a deeper understanding of Ascendis Pharma A/S ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.71 and its Current Ratio is at 1.04.
On April 16, 2025, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $205.
On January 07, 2025, UBS started tracking the stock assigning a Buy rating and target price of $196.UBS initiated its Buy rating on January 07, 2025, with a $196 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 07 ’25 when JENSEN FLEMMING STEEN bought 10,938 shares for $162.20 per share.
Shu Aimee bought 4,204 shares of ASND for $700,412 on May 06 ’25. On May 06 ’25, another insider, SPROGOE KENNETT, who serves as the Officer of the company, bought 10,000 shares for $170.05 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 24.66.
Stock Price History:
Over the past 52 weeks, ASND has reached a high of $183.00, while it has fallen to a 52-week low of $111.09. The 50-Day Moving Average of the stock is 2.94%, while the 200-Day Moving Average is calculated to be 15.85%.
Shares Statistics:
A total of 60.37M shares are outstanding, with a floating share count of 59.90M. Insiders hold about 0.78% of the company’s shares, while institutions hold 105.51% stake in the company.
